Literature DB >> 17476358

A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome.

Veronica Marrella1, Pietro Luigi Poliani, Anna Casati, Francesca Rucci, Laura Frascoli, Marie-Lise Gougeon, Brigitte Lemercier, Marita Bosticardo, Maria Ravanini, Manuela Battaglia, Maria Grazia Roncarolo, Marina Cavazzana-Calvo, Fabio Facchetti, Luigi D Notarangelo, Paolo Vezzoni, Fabio Grassi, Anna Villa.   

Abstract

Rag enzymes are the main players in V(D)J recombination, the process responsible for rearrangement of TCR and Ig genes. Hypomorphic Rag mutations in humans, which maintain partial V(D)J activity, cause a peculiar SCID associated with autoimmune-like manifestations, Omenn syndrome (OS). Although a deficient ability to sustain thymopoiesis and to produce a diverse T and B cell repertoire explains the increased susceptibility to severe infections, the molecular and cellular mechanisms underlying the spectrum of clinical and immunological features of OS remain poorly defined. In order to better define the molecular and cellular pathophysiology of OS, we generated a knockin murine model carrying the Rag2 R229Q mutation previously described in several patients with OS and leaky forms of SCID. These Rag2(R229Q/R229Q) mice showed oligoclonal T cells, absence of circulating B cells, and peripheral eosinophilia. In addition, activated T cells infiltrated gut and skin, causing diarrhea, alopecia, and, in some cases, severe erythrodermia. These findings were associated with reduced thymic expression of Aire and markedly reduced numbers of naturally occurring Tregs and NKT lymphocytes. In conclusion, Rag2(R229Q/R229Q) mice mimicked most symptoms of human OS; our findings support the notion that impaired immune tolerance and defective immune regulation are involved in the pathophysiology of OS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476358      PMCID: PMC1857243          DOI: 10.1172/JCI30928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.

Authors:  J Derbinski; A Schulte; B Kyewski; L Klein
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

2.  Epithelial heterogeneity in the murine thymus: a cell surface glycoprotein expressed by subcapsular and medullary epithelium.

Authors:  A Farr; A Nelson; J Truex; S Hosier
Journal:  J Histochem Cytochem       Date:  1991-05       Impact factor: 2.479

3.  The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.

Authors:  C Pannetier; M Cochet; S Darche; A Casrouge; M Zöller; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses.

Authors:  Annick Lim; Véronique Baron; Laurent Ferradini; Marc Bonneville; Philippe Kourilsky; Christophe Pannetier
Journal:  J Immunol Methods       Date:  2002-03-01       Impact factor: 2.303

5.  Aire regulates negative selection of organ-specific T cells.

Authors:  Adrian Liston; Sylvie Lesage; Judith Wilson; Leena Peltonen; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

Authors:  Cecile King; Alex Ilic; Kersten Koelsch; Nora Sarvetnick
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

7.  RAG mutations in human B cell-negative SCID.

Authors:  K Schwarz; G H Gauss; L Ludwig; U Pannicke; Z Li; D Lindner; W Friedrich; R A Seger; T E Hansen-Hagge; S Desiderio; M R Lieber; C R Bartram
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

9.  Two waves of recombinase gene expression in developing thymocytes.

Authors:  A Wilson; W Held; H R MacDonald
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.

Authors:  N A Hosken; K Shibuya; A W Heath; K M Murphy; A O'Garra
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  51 in total

1.  Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.

Authors:  Veronica Marrella; Pietro L Poliani; Elena Fontana; Anna Casati; Virginia Maina; Barbara Cassani; Francesca Ficara; Manuela Cominelli; Francesca Schena; Marianna Paulis; Elisabetta Traggiai; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 2.  Altered T-cell receptor signaling in the pathogenesis of allergic disease.

Authors:  Shrimati Datta; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

3.  The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2.

Authors:  Santiago Ramón-Maiques; Alex J Kuo; Dylan Carney; Adam G W Matthews; Marjorie A Oettinger; Or Gozani; Wei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

4.  Limited T-cell receptor diversity predisposes to Th2 immunopathology: involvement of Tregs and conventional CD4 T cells.

Authors:  Joshua Milner; William E Paul
Journal:  J Clin Immunol       Date:  2008-09-13       Impact factor: 8.317

Review 5.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Authors:  Ramona Goyal; Ariel C Bulua; Nikolay P Nikolov; Pamela L Schwartzberg; Richard M Siegel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

Review 6.  Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency--lessons learned from monogenic disorders in mice and men.

Authors:  Lisa S Westerberg; Christoph Klein; Scott B Snapper
Journal:  Curr Opin Immunol       Date:  2008-11-12       Impact factor: 7.486

Review 7.  Murine models of Omenn syndrome.

Authors:  Serre-Yu Wong; David B Roth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome.

Authors:  Janet Chou; Rima Hanna-Wakim; Irit Tirosh; Jennifer Kane; David Fraulino; Yu Nee Lee; Soha Ghanem; Iman Mahfouz; André Mégarbané; Gérard Lefranc; Adlette Inati; Ghassan Dbaibo; Silvia Giliani; Luigi D Notarangelo; Raif S Geha; Michel J Massaad
Journal:  J Allergy Clin Immunol       Date:  2012-07-25       Impact factor: 10.793

9.  Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency.

Authors:  Sebastian Fuchs; Anne Rensing-Ehl; Ulrich Pannicke; Myriam R Lorenz; Paul Fisch; Yogesh Jeelall; Jan Rohr; Carsten Speckmann; Thomas Vraetz; Susan Farmand; Annette Schmitt-Graeff; Marcus Krüger; Brigitte Strahm; Philipp Henneke; Anselm Enders; Keisuke Horikawa; Christopher Goodnow; Klaus Schwarz; Stephan Ehl
Journal:  Blood       Date:  2015-08-19       Impact factor: 22.113

10.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Authors:  Raif S Geha; Luigi D Notarangelo; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Alain Fischer; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Jennifer M Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2007-10       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.